New drug aims to tame COPD Flare-Ups and ease breathing
NCT ID NCT06897748
Summary
This study is testing an investigational drug called tozorakimab to see if it can help people with a specific type of COPD. It aims to improve lung function, reduce the frequency of symptom flare-ups (exacerbations), and ease daily symptoms like breathlessness and cough. The trial will compare the drug against a placebo in about 98 participants over several months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Aramil, 624002, Russia
-
Research Site
Izhevsk, 426061, Russia
-
Research Site
Moscow, 105554, Russia
-
Research Site
Moscow, 117546, Russia
-
Research Site
Moscow, 119048, Russia
-
Research Site
Moscow, 125284, Russia
-
Research Site
Omsk, 644099, Russia
-
Research Site
Penza, 440067, Russia
-
Research Site
Perm, 614000, Russia
-
Research Site
Saint Petersburg, 193231, Russia
-
Research Site
Saratov, 410054, Russia
-
Research Site
Ulyanovsk, 432009, Russia
Conditions
Explore the condition pages connected to this study.